Mass Tort brief
UK Class Actions and Mass Tort Liabilities
London competition and High Court rulings impose record payouts on Google and BHP while Reckitt faces US bellwether trials.
Mass Tort
English courts are holding BHP accountable for the Mariana dam disaster — forcing the mining giant to defend a £36 billion claim in London.
BackgroundThe 2015 Fundão dam collapse in Mariana, Brazil, destroyed entire communities and severely contaminated hundreds of miles of riverways. Affected residents and municipalities brought the largest group action lawsuit in English legal history against London-listed BHP.
- Nineteen Brazilian municipalities joined a $32.7 billion government compensation framework in South America earlier this month to secure localized funding.
- English judges determined that UK proceedings against BHP will continue regardless, setting parameters for a crucial liability trial scheduled for late 2026.
- The London litigation represents the largest environmental mass tort claim ever mounted in English courts, threatening unprecedented cash payout demands.
Mass Tort
Google is paying £260 million to end its UK app store litigation — establishing Britain's competition tribunal as a potent venue for tech class actions.
BackgroundThe UK Consumer Rights Act 2015 created an opt-out regime allowing representative lawsuits on behalf of affected businesses before the Competition Appeal Tribunal. App developers alleged Google abused its market dominance by charging mandatory 30% commission fees on digital purchases.
- The agreement awards £160 million directly to UK app developers who monetized digital products on Android devices between August 2018 and July 2026.
- An additional £100 million will cover legal representation and litigation funding expenses accumulated throughout four years of legal proceedings.
- The settlement represents the largest monetary payout ever achieved under Britain's collective action regime, subject to final judicial approval in September.
Mass Tort
Reckitt faces its first federal bellwether trial over infant formula — leaving FTSE 100 investors braced for billions in potential liability exposure.
BackgroundReckitt and competitor Abbott Laboratories face hundreds of lawsuits alleging cow's-milk-based infant formulas cause necrotizing enterocolitis in premature infants. Previous state court verdicts against both manufacturers produced multi-hundred-million-dollar jury awards that severely depressed company stock values.
- Mead Johnson executives testified in defense, maintaining that cow-milk formula fortifiers are medically vital for premature infant nutrition and survival.
- Co-defendant Abbott Laboratories recently agreed to a $670 million settlement resolving roughly 2,000 parallel infant formula claims across US courts.
- Analysts estimate Reckitt's total liability across 825 consolidated claims could hit £8 billion, creating sustained valuation headwinds for FTSE 100 investors.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
